ArticleBrain informatics2026
Cross-attention-guided subject-adaptive graph learning for multimodal autism classification: integrating structural and functional MRI data.
Article in Brain informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition marked by structural atypicality and abnormal functional connectivity. It remains challenging to accurately delineate an ASD-associated neural marker due to individual heterogeneity and multi-site data variability. To address these issues, we propose a cross-attention-guided subject-adaptive graph network (CAS-GNN) model that integrates structural MRI and resting-state functional connectivity data, effectively fusing complementary multimodal information. By modeling individualized brain network topologies and incorporating a site-invariant learning strategy, our approach enhances discriminability and cross-site generalization. On the ABIDE-I dataset, CAS-GNN significantly outperformed machine learning baselines and achieved an accuracy of 79.25% ± 4.71% on independent test data and an average accuracy of 78.75% ± 1.56% on five-fold cross-validation. Exploratory analyses identified key ASD-related brain regions and connections, revealing a notable right-hemisphere dominance consistent with atypical asymmetry in ASD. Our framework offers valuable neurobiological insights and provides a promising tool for interpretable and robust ASD diagnosis, accelerating biomarker discovery and development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.